AZN logo

AstraZeneca PLC (AZN) Operating Profit

Annual Operating Profit:

$10.00B+$1.28B(+14.69%)
December 31, 2024

Summary

  • As of today, AZN annual operating income is $10.00 billion, with the most recent change of +$1.28 billion (+14.69%) on December 31, 2024.
  • During the last 3 years, AZN annual operating profit has risen by +$10.14 billion (+7296.40%).
  • AZN annual operating profit is now -13.41% below its all-time high of $11.55 billion, reached on December 31, 2010.

Performance

AZN Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNincome statement metrics

Quarterly Operating Profit:

$3.55B+$96.13M(+2.78%)
September 30, 2025

Summary

  • As of today, AZN quarterly operating income is $3.55 billion, with the most recent change of +$96.13 million (+2.78%) on September 30, 2025.
  • Over the past year, AZN quarterly operating profit has increased by +$765.54 million (+27.48%).
  • AZN quarterly operating profit is now -21.45% below its all-time high of $4.52 billion, reached on March 31, 1999.

Performance

AZN Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNincome statement metrics

TTM Operating Profit:

$12.71B+$765.54M(+6.41%)
September 30, 2025

Summary

  • As of today, AZN TTM operating income is $12.71 billion, with the most recent change of +$765.54 million (+6.41%) on September 30, 2025.
  • Over the past year, AZN TTM operating profit has increased by +$2.55 billion (+25.11%).
  • AZN TTM operating profit is now at all-time high.

Performance

AZN TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNincome statement metrics

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

AZN Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+14.7%+27.5%+25.1%
3Y3 Years+7296.4%+173.4%+294.8%
5Y5 Years+475.6%+222.9%+220.3%

AZN Operating Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+7296.4%-3.5%+193.3%at high+294.8%
5Y5-Yearat high+7296.4%-3.5%+3651.5%at high+598.5%
All-TimeAll-Time-13.4%+7296.4%-21.4%+173.5%at high+7644.0%

AZN Operating Profit History

DateAnnualQuarterlyTTM
Sep 2025
-
$3.55B(+2.8%)
$12.71B(+6.4%)
Jun 2025
-
$3.46B(-6.2%)
$11.94B(+5.4%)
Mar 2025
-
$3.68B(+82.5%)
$11.33B(+4.0%)
Dec 2024
$10.00B(+14.7%)
$2.02B(-27.6%)
$10.89B(+7.2%)
Sep 2024
-
$2.79B(-1.9%)
$10.16B(+8.3%)
Jun 2024
-
$2.84B(-12.5%)
$9.38B(+12.5%)
Mar 2024
-
$3.25B(+152.5%)
$8.33B(+12.2%)
Dec 2023
$8.72B(+93.3%)
$1.28B(-36.0%)
$7.42B(+1.0%)
Sep 2023
-
$2.01B(+11.9%)
$7.35B(+10.7%)
Jun 2023
-
$1.79B(-23.2%)
$6.64B(+20.6%)
Mar 2023
-
$2.34B(+92.9%)
$5.51B(+36.8%)
Dec 2022
$4.51B(+3346.0%)
$1.21B(-6.8%)
$4.03B(+25.1%)
Sep 2022
-
$1.30B(+96.5%)
$3.22B(+76.9%)
Jun 2022
-
$661.00M(-22.7%)
$1.82B(-18.3%)
Mar 2022
-
$855.00M(+112.2%)
$2.23B(-30.9%)
Dec 2021
-$139.00M(-103.5%)
$403.00M(+503.0%)
$3.22B(-24.8%)
Sep 2021
-
-$100.00M(-109.4%)
$4.29B(-21.9%)
Jun 2021
-
$1.07B(-42.2%)
$5.49B(-3.3%)
Mar 2021
-
$1.85B(+26.2%)
$5.67B(+14.2%)
Dec 2020
$3.92B(+125.3%)
$1.47B(+33.3%)
$4.97B(+25.2%)
Sep 2020
-
$1.10B(-12.4%)
$3.97B(+8.5%)
Jun 2020
-
$1.25B(+9.6%)
$3.66B(+25.9%)
Mar 2020
-
$1.15B(+145.2%)
$2.90B(+0.8%)
Dec 2019
$1.74B(+236.8%)
$467.00M(-40.9%)
$2.88B(-23.1%)
Sep 2019
-
$790.00M(+57.1%)
$3.75B(-2.4%)
Jun 2019
-
$503.00M(-55.2%)
$3.84B(-6.6%)
Mar 2019
-
$1.12B(-15.8%)
$4.11B(+24.2%)
Dec 2018
$516.00M(-74.9%)
$1.33B(+51.2%)
$3.31B(+67.5%)
Sep 2018
-
$881.00M(+13.7%)
$1.98B(-12.2%)
Jun 2018
-
$775.00M(+140.7%)
$2.25B(+13.6%)
Mar 2018
-
$322.00M(>+9900.0%)
$1.98B(-23.1%)
Dec 2017
$2.05B(-42.6%)
-$2.00M(-100.2%)
$2.58B(-41.2%)
Sep 2017
-
$1.16B(+128.5%)
$4.39B(-0.8%)
Jun 2017
-
$506.00M(-44.8%)
$4.42B(+6.4%)
Mar 2017
-
$917.00M(-49.3%)
$4.16B(-5.0%)
Dec 2016
$3.57B(+16.5%)
$1.81B(+51.6%)
$4.38B(+23.0%)
Sep 2016
-
$1.19B(+394.6%)
$3.56B(+7.9%)
Jun 2016
-
$241.00M(-78.8%)
$3.30B(-17.9%)
Mar 2016
-
$1.14B(+15.1%)
$4.02B(+10.1%)
Dec 2015
$3.07B(+28.3%)
$989.00M(+6.2%)
$3.65B(+50.2%)
Sep 2015
-
$931.00M(-2.9%)
$2.43B(+4.9%)
Jun 2015
-
$959.00M(+24.7%)
$2.32B(-12.3%)
Mar 2015
-
$769.00M(+434.6%)
$2.64B(-13.9%)
Dec 2014
$2.39B(-35.4%)
-$229.83M(-128.1%)
$3.07B(-37.1%)
Sep 2014
-
$818.00M(-36.3%)
$4.88B(-15.9%)
Jun 2014
-
$1.28B(+7.4%)
$5.80B(-0.3%)
Mar 2014
-
$1.20B(-24.4%)
$5.82B(-9.0%)
Dec 2013
$3.70B(-53.1%)
$1.58B(-8.9%)
$6.39B(-8.5%)
Sep 2013
-
$1.74B(+33.6%)
$6.99B(-2.1%)
Jun 2013
-
$1.30B(-26.6%)
$7.13B(-7.7%)
Mar 2013
-
$1.77B(-18.5%)
$7.73B(-9.2%)
Dec 2012
$7.88B(-30.1%)
$2.17B(+15.3%)
$8.51B(-2.4%)
Sep 2012
-
$1.89B(-0.5%)
$8.72B(-8.5%)
Jun 2012
-
$1.90B(-25.7%)
$9.53B(-9.7%)
Mar 2012
-
$2.55B(+7.1%)
$10.56B(-7.1%)
Dec 2011
$11.28B(-2.4%)
$2.38B(-11.6%)
$11.36B(-8.3%)
Sep 2011
-
$2.70B(-7.9%)
$12.39B(+4.1%)
Jun 2011
-
$2.93B(-12.9%)
$11.90B(-0.0%)
Mar 2011
-
$3.36B(-1.4%)
$11.91B(+0.2%)
Dec 2010
$11.55B(+5.1%)
$3.41B(+54.1%)
$11.88B(+6.4%)
Sep 2010
-
$2.21B(-24.5%)
$11.16B(-8.6%)
Jun 2010
-
$2.93B(-12.1%)
$12.21B(+2.2%)
Mar 2010
-
$3.33B(+23.9%)
$11.95B(+3.2%)
Dec 2009
$10.99B(+20.2%)
$2.69B(-17.4%)
$11.58B(+6.6%)
Sep 2009
-
$3.26B(+22.0%)
$10.86B(+8.5%)
Jun 2009
-
$2.67B(-10.0%)
$10.01B(+3.8%)
Mar 2009
-
$2.97B(+50.7%)
$9.64B(+9.1%)
DateAnnualQuarterlyTTM
Dec 2008
$9.14B(+13.0%)
$1.97B(-18.2%)
$8.84B(+0.9%)
Sep 2008
-
$2.41B(+4.6%)
$8.76B(+6.6%)
Jun 2008
-
$2.30B(+6.6%)
$8.22B(+5.0%)
Mar 2008
-
$2.16B(+14.3%)
$7.83B(+0.6%)
Dec 2007
$8.09B(-1.5%)
$1.89B(+1.4%)
$7.78B(+0.1%)
Sep 2007
-
$1.86B(-2.6%)
$7.77B(-1.5%)
Jun 2007
-
$1.91B(-9.5%)
$7.89B(+0.0%)
Mar 2007
-
$2.11B(+12.4%)
$7.89B(+2.9%)
Dec 2006
$8.22B(+26.4%)
$1.88B(-5.1%)
$7.67B(+4.3%)
Sep 2006
-
$1.98B(+3.7%)
$7.35B(+5.5%)
Jun 2006
-
$1.91B(+1.0%)
$6.97B(+3.6%)
Mar 2006
-
$1.89B(+20.8%)
$6.73B(+7.2%)
Dec 2005
$6.50B(+43.0%)
$1.57B(-1.9%)
$6.27B(+5.9%)
Sep 2005
-
$1.60B(-4.4%)
$5.93B(+8.0%)
Jun 2005
-
$1.67B(+16.1%)
$5.49B(+14.6%)
Mar 2005
-
$1.44B(+18.1%)
$4.79B(+7.8%)
Dec 2004
$4.55B(+13.5%)
$1.22B(+5.4%)
$4.44B(+10.9%)
Sep 2004
-
$1.16B(+19.0%)
$4.00B(+3.2%)
Jun 2004
-
$972.31M(-11.0%)
$3.88B(+3.1%)
Mar 2004
-
$1.09B(+39.8%)
$3.76B(-5.5%)
Dec 2003
$4.01B(+0.0%)
$781.00M(-24.4%)
$3.98B(-6.5%)
Sep 2003
-
$1.03B(+20.8%)
$4.26B(+2.0%)
Jun 2003
-
$855.80M(-34.7%)
$4.17B(+25.8%)
Mar 2003
-
$1.31B(+24.2%)
$3.32B(+0.4%)
Dec 2002
$4.01B(-3.6%)
$1.06B(+10.9%)
$3.30B(+0.9%)
Sep 2002
-
$951.92M(>+9900.0%)
$3.27B(+1.1%)
Jun 2002
-
$0.00(-100.0%)
$3.24B(-22.3%)
Mar 2002
-
$1.30B(+26.4%)
$4.17B(+5.8%)
Dec 2001
$4.16B(-7.1%)
$1.03B(+12.1%)
$3.94B(+13.6%)
Sep 2001
-
$915.39M(-1.7%)
$3.47B(+2.6%)
Jun 2001
-
$930.83M(-12.9%)
$3.38B(-5.6%)
Mar 2001
-
$1.07B(+92.5%)
$3.58B(+3.7%)
Dec 2000
$4.47B(+30.4%)
$555.00M(-32.9%)
$3.45B(+1.5%)
Sep 2000
-
$826.77M(-26.9%)
$3.40B(-2.3%)
Jun 2000
-
$1.13B(+20.3%)
$3.48B(+3.6%)
Mar 2000
-
$940.03M(+86.5%)
$3.36B(-51.6%)
Dec 1999
$3.43B(+41.3%)
$504.00M(-44.5%)
$6.94B(+332.0%)
Sep 1999
-
$908.00M(-10.0%)
$1.61B(-47.0%)
Jun 1999
-
$1.01B(-77.7%)
$3.03B(+12.0%)
Mar 1999
-
$4.52B(+193.6%)
$2.71B(+350.0%)
Dec 1998
$2.43B(+34.0%)
-$4.83B(-307.3%)
$601.10M(-36.5%)
Sep 1998
-
$2.33B(+240.2%)
$946.31M(+32.3%)
Jun 1998
-
$685.00M(-71.7%)
$715.51M(-69.1%)
Mar 1998
-
$2.42B(+153.9%)
$2.31B(+6.1%)
Dec 1997
$1.81B(-3.0%)
-$4.49B(-313.7%)
$2.18B(-44.2%)
Sep 1997
-
$2.10B(-8.1%)
$3.91B(-5.2%)
Jun 1997
-
$2.28B(0.0%)
$4.12B(+0.1%)
Mar 1997
-
$2.28B(+182.8%)
$4.12B(+0.1%)
Dec 1996
$1.87B(+11.1%)
-$2.76B(-219.2%)
$4.11B(+49.7%)
Sep 1996
-
$2.31B(+1.5%)
$2.75B(+16.0%)
Jun 1996
-
$2.28B(0.0%)
$2.37B(+405.5%)
Mar 1996
-
$2.28B(+155.3%)
$468.49M(+126.2%)
Dec 1995
$1.68B(+40.9%)
-$4.12B(-313.1%)
$207.09M(-40.2%)
Sep 1995
-
$1.94B(+411.0%)
$346.28M(+111.0%)
Jun 1995
-
$378.70M(-81.2%)
$164.08M(-89.9%)
Mar 1995
-
$2.02B(+150.6%)
$1.62B(+12.5%)
Dec 1994
$1.19B(+17.0%)
-$3.98B(-327.3%)
$1.44B(+2.1%)
Sep 1994
-
$1.75B(-4.6%)
$1.41B(+18.0%)
Jun 1994
-
$1.84B(0.0%)
$1.20B(+8.0%)
Mar 1994
-
$1.84B(+145.8%)
$1.11B(+8.7%)
Dec 1993
$1.02B(+7.9%)
-$4.01B(-361.2%)
$1.02B(-79.8%)
Sep 1993
-
$1.54B(-12.1%)
$5.03B(+44.0%)
Jun 1993
-
$1.75B(0.0%)
$3.50B(+100.0%)
Mar 1993
-
$1.75B
$1.75B
Dec 1992
$944.90M(-25.5%)
-
-
Dec 1991
$1.27B(-2.9%)
-
-
Dec 1990
$1.31B
-
-

FAQ

  • What is AstraZeneca PLC annual operating income?
  • What is the all-time high annual operating profit for AstraZeneca PLC?
  • What is AstraZeneca PLC annual operating profit year-on-year change?
  • What is AstraZeneca PLC quarterly operating income?
  • What is the all-time high quarterly operating profit for AstraZeneca PLC?
  • What is AstraZeneca PLC quarterly operating profit year-on-year change?
  • What is AstraZeneca PLC TTM operating income?
  • What is the all-time high TTM operating profit for AstraZeneca PLC?
  • What is AstraZeneca PLC TTM operating profit year-on-year change?

What is AstraZeneca PLC annual operating income?

The current annual operating profit of AZN is $10.00B

What is the all-time high annual operating profit for AstraZeneca PLC?

AstraZeneca PLC all-time high annual operating income is $11.55B

What is AstraZeneca PLC annual operating profit year-on-year change?

Over the past year, AZN annual operating income has changed by +$1.28B (+14.69%)

What is AstraZeneca PLC quarterly operating income?

The current quarterly operating profit of AZN is $3.55B

What is the all-time high quarterly operating profit for AstraZeneca PLC?

AstraZeneca PLC all-time high quarterly operating income is $4.52B

What is AstraZeneca PLC quarterly operating profit year-on-year change?

Over the past year, AZN quarterly operating income has changed by +$765.54M (+27.48%)

What is AstraZeneca PLC TTM operating income?

The current TTM operating profit of AZN is $12.71B

What is the all-time high TTM operating profit for AstraZeneca PLC?

AstraZeneca PLC all-time high TTM operating income is $12.71B

What is AstraZeneca PLC TTM operating profit year-on-year change?

Over the past year, AZN TTM operating income has changed by +$2.55B (+25.11%)
On this page